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Five brain tumors with the histopathologic features of pleomorphic 
xanthoastrocytomas (PXAs) are presented. Computed tomography 
scans showed a remarkable homology. Two cases had atypical lo- 
calizations for a PXA, while one 46-year-old patient did not conform 
to the normal age distribution of this tumor. Nevertheless, in these 
cases, the histopathology was always characteristic for PXA, a re- 
markable pleomorphism, in addition to simultaneous expression 
of glial fibrillary acidic protein and histiocytic markers in the various 
tumor cells. In one of the presented tumors, however, clusters of 
neoplastic neuronal cells were also found. In this particular case, 
differential diagnostic criteria to distinguish between a PXA and a 
desmoplastic infantile ganglioglioma are lacking. HUM PATHOL 22: 
1128-l 135. Copyright 0 1991 by W.B. Saunders Company 
In 1979, Kepes et al described 12 young patients 
with superficial brain tumors with extensive involvement 
of the leptomeninges.’ In spite of an impressive pleo- 
morphism, necrosis was never found in these tumors, 
and mitoses were scanty. The presence of intracyto- 
plasmic lipid droplets in part of the tumor cells, as well 
as a basal lamina around individual cells, supported the 
initial view that these highly pleomorphic neoplasms 
represented a variant of meningocerebral fibrous xan- 
thomas.’ Once the expression of glial fibrillary acidic 
protein (GFAP) was found in the tumor cells, however, 
these neoplasms were considered to be variants of as- 
trocytomas and, subsequently, were termed “pleomor- 
phic xanthoastrocytomas” (PXAs).’ In contrast to their 
ominous histopathology, the clinical courses appeared 
to be relatively favorable.’ Therefore, distinction of 
PXAs from other pleomorphic gliomas is important. The 
presence of necrosis in a pleomorphic intracerebral tu- 
mor should definitely exclude the diagnosis of PXA, 
since necrosis is invariably linked with malignancy.“.4 
Several cases of PXA have been described.“-‘” Some 
of these had exceptional clinical features. In contrast 
with the typical young age of incidence of PXAs, a 62- 
year-old man was described by Mackenzie.” Unusual 
localizations of PXAs were the suprasellar region and 
the floor of the medial skull fossa.8.‘7 Furthermore, 
PXAs with extensive recurrences after initial o eration 
and rapid fatal outcomes have been reported. R-21 
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Despite some atypical clinical features, the histo- 
pathology of the present five cases was compatible with 
the entity of PXA. However, in one of the presented 
tumors, neoplastic neuronal cells were found. The dif- 
ferential diagnosis of PXA and of this case, in particular, 
are discussed. 
MATERIALS AND METHODS 
Conventional Staining and 
lmmunohistochemistry 
Pleomorphic tumors with malignant appearance from pa- 
tients with unexpected benign courses as well as from patients 
with a primary diagnosis of PXA were reviewed. The paraffin- 
embedded material from five selected cases was retrieved from 
the archives and new sections were made. The slides were 
stained with hematoxylin-eosin, periodic acid-Schiff for mu- 
copolysaccharides and glycogen, Nissl stain for the Nissl sub- 
stance, and Bodian stain for visualization of axon bundles. 
For immunohistochemistry, the slides were incubated with 
antibodies against vimentin, keratin. desmin, epithelial mem- 
brane antigen, SlOO protein, GFAP, neuron-specific enolase, 
lysozyme (muramidase), (Y- 1 -antitrypsin, (Y- 1 -antichymotrypsin, 
neurofilament (monoclonal reacting with 70- and 200-kd pro- 
teins), and synaptophysin. The primary antibodies were ob- 
tained from DAK0 (Copenhagen, Denmark). Immunohisto- 
chemistry on 5 pm-thick sections of the paraffin-embedded 
material was done with the two-step indirect immunoperoxi- 
dase technique as described previously.” Final visualization 
was achieved by incubation with 0.02% diaminobenzidine in 
phosphate-buffered saline and 0.075% H202. Control slides, 
in which the primary antibody was replaced by phosphate- 
buffered saline, were always negative. The slides were slightly 
counterstained with hematoxylin to determine the cellular 
morphology. For keratin staining a mild proteolytic treatment 
with pronase (Sigma no. P5147, St Louis, MO) was performed 
(0.1% pronase for 15 minutes at room temperature) to demask 
the keratin epitopes. 
RESULTS 
Patients and Computed Tomography Scan 
Findings 
The clinical data of the five cases are summarized 
in Table 1. One patient (case no. 4) was 46 years old. 
The tumor in this patient was located in the thalamus. 
The patient died after 3 years due to tumor progression. 
Although a stereotactic operation was performed, suf- 
ficient material for reliable diagnosis was available. Case 
no. 5 presented with a tumor located in the temporal 
lobe with extension into the thalamus. 
On a computed tomography (CT) scan, the lesions 
showed uniform intense contrast enhancing (Fig 1). The 
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TABLE 1. Clinical Data of the Five Patients 
lesions wertx sharpI) demarcated. with brain edema ex- 
tending into the white matter. In three patients (nos. 1, 
2, and 3) the tumors were located at the convexity, with 
brain edema extending centrally into the white matter. 
Two patients (nos. 1 and 5) had centrally located lesions, 
including thr thalamus. with no or only mild develop- 
ment of brain edema (Fig 1). 
Histopathologic Features 
A marked pleomorphism was an invariable tinding 
in ‘41 five p,atients (Fig PA). Xanthomatous cells as well 
as polygonal cells with eosinophilic hyaline granules in 
the cytoplasm! were seen among irregular bundles of 
spindle-shaped cells (Fig ‘LA, C, D, E, and F). Further- 
more, gemistocvtic cells, giant cells (some of which were 
polynuclear), and nude nuclei without recognizable cy- 
toplasm were seen (Fig ‘LA and G). Many periodic acid- 
Schiff-positive. diastase-resistant granules were present 
in par’ of thie tumor cells (Fig 9E). Only sporadic mitoses 
were noted. In AI five cases necrosis was definitely ab- 
sent. Vascular proliferation was not obvious. Keticulin 
staining revealed a fiber network surrounding individual 
tumor cells (ie. both the polygonal cells and the spindle- 
shaped cells) (Fig 2F). Focal infiltratrs of Ivmphocytes 
and plasma cells were found (Fig ?A). 
In case no. 5 clusters of neuronal elements were 
seen dispersed between the other tumor elements (Fig 
2H-1,). The neoplastic nature of the neuronal elements 
was supper-ted by their pleomorphism ad random ori- 
entation: they sometimes formed clusters (Fig ZK). The 
(IW neuronal nature of these neoplastic cells was proven 
bv the presence of Nissl substance in addition to im- 
n;unohistc,chemical profiles (see below) (Fig 21). 
lmmunohistochemistry 
In all tumors a majority of the tumor cells stained 
positive for anti-GFAP‘antibody (Table 2; Fig 2s) and 
for anti-vimentin, as well as for the histioc ytic markers 
CU-1 -antitrypsin and a-1 - ;Inti~hyrllot~psin (Table 2; Fig 
XI). Furthermore, the tumor cells express4 Sl 00 pro- 
tein and neuron-specific enolase (Table I!). In none of‘ 
the cells was immunostaining acquired for anti-keratin 
xid anti-Iysozynie (Table 2). 
In the neoplastic neuronal cells of c’ase no. :i the 
perikaryon and the cell processes wcrc positive for neu- 
rotilament (Fig 2.1). Intense positifit! for anti-svnapto- 
FIGURE 1. Computed tomography scan findings. (Left) Case no. 2. Computed tomography idiosyncrasies of a PXA, a parietal 
located, partly cystic tumor, firmly connected with the dura. (Right) Case no. 5. Cystic tumor with deep temporal location, extending 
into the thalamus. No connection with the dura is noted. 
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FIGURE 2. Histopathologic and immunohistochemical pictures. (A) Case no. 1. Low-power magniftcation of a typical PXA: a 
moderately cellular, marked pleomorphic tumor, without necrosis. (Hematoxylin-eosin stain; magnification X9.) (B) Case no. 1. 
lmmunopositivity for GFAP of the various tumor cells. Round cells as well as spindle-shaped cells are positive for GFAP. (Peroxidase 
antiperoxidose [PAP] stain for GFAP: magnification X79.) (C) Case no. I. lmmunopositivity for a-I-antichymotrypsin in the PXA. The 
expression is variable. (PAP stain for tu-I-antichymotrypsin; magnification x79.) (D) Case no. I. Xanthomatous cell (“lipid-laden 
cell”): polygonal cell with confluent vacuoles in the cytoplasm. (Hematoxylin-eosin stain; magnification x264.) (E) Case no. 1. 
Eosinophilic hyaline granular cell: this cell was described in detail OS a constituent of the PXAs by lwaki et al.’ lntracytoplasmatic 
eosinophilic granules are found, which stain strongly with periodic acid-Schiff. (Magnification x264.) (F) Case no. I. Spindle-shaped 
cell. Reticulin is not exclusively found around this cell type, but surrounds the lipid-laden cells as well. (Gomori stain; magnification 
x264.) (G) Case no. 3. Multinuclear giant cell (Touton-like giant cell). A variety of larger cells are seen in the PXA, ranging from 
gemistocytic cells to monstrous cells. The nuclei of the Touton-like cells have an (almost) circular arrangement. (Hematoxylin-eosin 
stain; magnification x264.) (H) Case no. 5. Neuronal cell (arrow) in a highly pleomorphic tumor indistinguishable from the PXA. 
(Hematoxylin-eosin stain; magnification XI 15.) (I) Case no. 5. Among the neuronal cells in case no. 5, several binucleated cells 
were found. (Nissl stain; magnification x264.) (J) Case no. 5. Neuronol cell (arrow) PAP stained for neuroftlament. (Magnification 
x264.) (K) Case no. 5. Cluster of neuronal cells (arrows). The random orientation and pleomorphism, in addition to strong positivity 
for synaptophysin, indicate the neoplostic nature of these cells. (PAP stain for synaptophysin; magnification X79.) (L) Case no. 5. 
Higher magnification of neuronal cell, stained for synaptophysin. lmmunostaining is seen in the perikaryon as well as in and around 
the cell processes. (PAP stain for synaptophysin: magnification X264.) 
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FIGURE 2. (Continued) 
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FIGURE 2. (Continued) 
physin antibody was seen in the cytoplasm and in and surrounding brain tissue, and contrast enhancement was 
around the cell processes (Fig 2K and L). a constant finding. Cysts were seen in all tumors. The 
CT scan findings are not specific for PXAs, however, 
DISCUSSION 
since comparable scans are found in a variety of other 
benign as well as malignant brain tumors.“.“‘.‘” 
Despite a similar histopathology, the presented 
Comparison of the CT scans of the present five cases had discrepant clinical data. Although one case of 
patients (Fig 1) with photomicrographs of CT scans in 
the literature”.I:‘.I7.‘“.” 
P2L4 has been described before in an elderly patient,” 
revealed a remarkable similarity. PXAs usually appear in young people. One of our pa- 
The lesions invariably showed distinct borders with the tients was 46 years old. In this patient and in one other 
TABLE 2. lmmunohistochemical Results 
ker vim gfa ‘Ys t r p chv nse Ill s 1 00 syn 
Spindle-shaped cells + + _ + + + + _ 
Xanthomatous cells _ + + _ + + + t _ 
Cells with eosinophilic 
hyaline granules + + _ + + + + _ 
Gemistocytic c-ells _ t + _ + + + t _ 
Giant cells _ + _ + + -+ + -. 
Touton-type giant cells _ _ + _ + + 
Newonal cells _ _ _ + + + 
Symbols: -, negative; +, positive; *. fXnt immunostaining. 
Abbreviations: ker, keratin: vim. vimentin; gfa, glial fibrillary acidic protein; lys, lysozyme (murarninidase); trp, a-I-trypsin; thy. a-l -c-hy- 
nrotrypsin; “se. neuron-specific enolase; nf, new&lament: SlOO, SlOO protein; syn, synaptophysin. 
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(no. 5), the tumor was located in a deep region (ie, the 
thalamus) (Fig 1, right). These cases and a few others 
in the liter,ature illustrate that PXAs ma be found in 
sites without obvious meningeal contact. B .” 
Almost all cell types simultaneously expressed 
GFAP as well as the histiocytic markers a-1-antitrypsin 
and cu-1-antichymotrypsin (Table 2; Fig 2B and C). Al- 
though int r-acranial localized malignant fibrous histio- 
cytomas may show pleomorphism as well, there is defi- 
nitely no (expression of GFAP in these tumors.“‘-“’ 
Despite morphologic and immunohistochemical simi- 
larities between PXAs and meningeal-derived fibrous 
histiocytomas, Kepes et al believe that PXAs represent 
primary glial, and not mesenchymal, neoplasms.21 In 
spite of the presence of reticulin, collagen depositions, 
(hemi)desmosomes, and intracytoplasmic lipid droplets, 
the marked GFAP positivity of the tumor cells was seen 
as a definite sign of the true glial nature of this tumor.” 
Paulus and. Peiffer, however, disputed its true glial na- 
ture because of the positivity of the tumor for mono- 
cytic-histiocytic markers, in addition to the distinct mes- 
enchymal features.” According to their observations, 
the presence of GFAP-positive cells would be limited to 
areas of cortical infiltration and might be explained by 
endocytic processes of histiocytic cells or by migration 
of’reactive astrocytes into the primary mesenchymal tu- 
mor.” If the PXA indeed represents a meningeal-de- 
rived tumor, the occurrence of this entity in nonsuper- 
ficial parts of the brain, such as the thalamus, is not 
easily explained. Moreover, in our cases, the expression 
of GFAP was not restricted to nonsuperficial tumor cells 
(Fig 2b). Whatever histogenesis PXAs Inay have, it should 
be kept in mind that expression of any marker could 
very well be the result of capricious behavior of the 
tumor cells rather than the indication of a supposed 
nonneoplastic cell of tumor origin.“’ 
Necrosis has been identified as a histopathologic 
feature with independent prognostic significance in 
gliomas.“” Based on the strict absence of this feature in 
PXAs, these tumors should be distinguished from 
gliomas with heavily lipidized tumor cells:‘.” (Table 3), 
as well as from monstrocellular brain tumors in which 
necrosis invariably heralds a bad prognosis.‘” Although 
the lengths of survival in monstrocellular glioblastomas 
are longer than those in less pleomorphic subtypes, 
they differ considerably from those recorded in cases 
of PXA.’ 
The presence of necrosis in two putative cases of 
PXA presented by Gaskill et al was linked with the 
rapid death of one of the patients,“’ while it was also 
the cause of criticism surrounding the a’ccuracy of the 
histopathologic diagnosis.“’ However, some investi- 
gators have suggested that anaplastic evolution of 
PXAs, associated with necrosis, might occur.‘!‘.” 
Moreover, the transition of a PXA into a glioblastoma 
with necrosis as a genuine feature has been inter- 
preted as further corroboration of the true glial na- 
ture of the former.“’ 
t t 
+ ti: 
The superficial cerebral astrocytomas that were 
found in some very young children by Taratuto et al’” 
and Chadarkvian et al”’ may be confused with PXAs, 
but clinical data and histopathology are distinct from 
the latter. Although superficial cerebral astrocytomas 
contain spindle-shaped cells and gemistocytic cells, lip- 
idized cells are sporadic and the degree of pleomorphism 
is not as pronounced as in PXAs (Table 3). Because of 
GFAP positivity, the superficial cerebral astrocytomas 
are believed to be glial tumors as well.“” Just as in the 
PXA. the subpial astrocytic subset has been considered 
as a possible ontogenic lineage for these superficial lo- 
calized neoplasms.‘“.“’ 
Our finding of neoplastic neuronal cells in an 
otherwise typical PXA (case no. 5) has not been reported 
previously. The neuronal cells presented with several 
degrees of maturation. Binucleated neuronal cells were 
frequently seen (Fig 21). The presence of Nissl substance, 
in addition to the expression of neurofilament and syn- 
aptophysin, was a signpost for the true neuronal char- 
acter of these cells”“,“” (Fig 21-L), while the random ori- 
entations and clustering are indicative of their neoplastic 
status (Fig 2K). Their presence had, in this case, led to 
a primary diagnosis of ganglioglioma (ie, desmoplastic 
infantile ganglioglioma [DIG]).“’ Gangliogliomas and 
ganglioneuromas may very well be found in the floor of 
the third ventricle, although they might arise anywhere 
else in the brain,““,““-“’ whereas DIGS are only encoun- 
tered in peripheral parts’)’ (Table 3). Although pleo- 
morphism may be present either in the glial or in the 
neuronal cell component of gangliogliomas, the glial 
part would be responsible for occasional malignant 
transformation of these tumors.“” In exceptional cases, 
gangliogliomas transform into glioblastomas.“H-“” The 
variants of DIGS affect young children and usually pres- 
ent as huge tumors affecting more than one cerebral 
lobe” (Table 3). 
Desmoplastic infantile ganglioglioma and PXA do 
share a number of clinical and histopathologic charac- 
teristics (Table 3). Both contain GFAP-positive cells, and 
both are preferentially associated with the leptomenin- 
ges. The distinction between PXAs and DIGS, however, 
is based on the finding of xanthomatous cells in the 
former, while neoplastic neuronal cells should be ex- 
clusively diagnostic for gangliogliomas (ie, DIGS).‘,“’ 
Therefore, the presence of xanthomatous cells in ad- 
dition to neoplastic ganglion cells in our case no. 5 
causes difficulties in the differential diagnosis. Fortu- 
nately, the distinction between a PXA with a neoplastic 
neuronal component on the one hand and a DIG with 
xanthomatous cells on the other appears to be irrelevant 
with respect to the expected biologic behavior. 
In conclusion, we believe that, due to its relatively 
favorable prognosis and characteristic histopathology, 
the pleomorphic xanthoastrocytoma definitely repre- 
sents a separate entity. If neuronal elements are ac- 
cepted as a possible constituent of this tumor, its dis- 
tinction from DIGS may be impossible. 
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